Lara Lorenzetti, Emily Namey, Melissa Corkum, Ademe Tsegaye, Gloria Lihemo, Douglas Mbang Massom, Deepa Risal Pokharel, Grace McLain, Ross Mcintosh
Despite widespread acceptance of the oral polio vaccine (OPV), vaccine hesitancy towards OPV in some countries presents a barrier to global eradication efforts. Between 2021 and 2022, the Global Polio Eradication Initiative implemented OPV campaigns concurrently with the roll-out of Covid-19 vaccines, for which vaccine hesitancy is well-documented. We sought to understand stakeholder perceptions of OPV and Covid-19 vaccines in Cameroon and Ethiopia. We implemented 32 focus group discussions (16 per country) with n = 216 caregivers of children under 5 and polio frontline workers to understand reasons for hesitancy, which included: fear of side effects, fear of vaccine overdosing, religious leaders being against vaccines and a lack of confidence in health workers, among others. These concerns were especially prominent toward the introduction of Covid-19 vaccines, less so toward OPV. Hesitancy reasons were more often reported as a concern held by community members, rather than participants themselves. Despite concerns, 69% of Ethiopian and 57% of Cameroonian respondents had received a Covid-19 vaccine. Our findings suggest a need for continued efforts to listen to caregiver and health worker concerns and co-create local solutions to enhance vaccine acceptability. Building trust amongst populations and addressing commonly held misconceptions is integral to vaccine introduction plans.